The Triglycerides-Glucose Index Shows a Stronger Correlation with Serum Adiponectin Levels than Homeostasis Model Assessment of Insulin Resistance and Quantitative Insulin Sensitivity Check Index.

To evaluate the association between diverse surrogate markers of insulin resistance and adiponectin concentrations. Four hundred healthy participants were included. Two different cohorts were formed according to the body mass index (BMI) values. Group 1 ( = 200) consisted of individuals with normal BMI values (18.50-24.99 kg/m), whereas in Group 2 ( = 200) there were overweight or obese individuals (BMI ≥25.00 kg/m). Homeostasis model assessment of insulin resistance (HOMA-IR), quantitative insulin sensitivity check index (QUICKI), and triglycerides-glucose index (TyG) were calculated. Serum adiponectin levels were measured by ELISA. A correlation analysis was performed to assess the association between serum adiponectin and HOMA-IR, QUICKI, and TyG. Participants in Group 2 were older (age in years: Group 1, 33.3 ± 6.8 vs. Group 2, 36.4 ± 7.0,  < 0.001). There was no gender difference between groups. Overweight or obese participants had higher BMI, waist circumference, fat mass, fat ratio, fasting plasma glucose, fasting plasma insulin, triglycerides, total cholesterol, and low-density lipoprotein cholesterol values, whereas high-density lipoprotein cholesterol was higher in participants with normal BMI measures. Overweight or obese subjects were more insulin resistant (higher TyG index and HOMA-IR) and less insulin sensitive (lower QUICKI),  < 0.001 for all. Serum adiponectin levels were lower in Group 2 (serum adiponectin in ng/mL: Group 1, 11,880 ± 6838 vs. Group 2, 9115 ± 5766,  < 0.001). The correlation between TyG index and adiponectin was stronger than the correlation between QUICKI and adiponectin, and HOMA-IR and adiponectin ( for TyG and adiponectin -0.408, for QUICKI and adiponectin 0.394, for HOMA-IR and adiponectin -0.268, respectively,  < 0.001 for all correlations). TyG has a stronger association with adiponectin than HOMA-IR and QUICKI.